Although all these variants have been detected in both cancer and control samples, the authors did not report a significant prevalence of these SNPs in patients with ovarian cancer, suggesting that these variations of NQO1 may not be linked to ovarian cancer development [41]. This evidence concerns the gene NQO1 and ovarian carcinoma.